Variable Characteristics of Bacteriocin-producing Streptococcus Salivarius Strains Isolated from Malaysian Subjects

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2014 Jun 19

PMID 24941127

Citations 12

Authors

Abdelahhad Barbour

Koshy Philip

Affiliations

Soon will be listed here.

Abstract

Background: Salivaricins are bacteriocins produced by Streptococcus salivarius, some strains of which can have significant probiotic effects. S. salivarius strains were isolated from Malaysian subjects showing variable antimicrobial activity, metabolic profile, antibiotic susceptibility and lantibiotic production.

Methodology/principal Findings: In this study we report new S. salivarius strains isolated from Malaysian subjects with potential as probiotics. Safety assessment of these strains included their antibiotic susceptibility and metabolic profiles. Genome sequencing using Illumina's MiSeq system was performed for both strains NU10 and YU10 and demonstrating the absence of any known streptococcal virulence determinants indicating that these strains are safe for subsequent use as probiotics. Strain NU10 was found to harbour genes encoding salivaricins A and 9 while strain YU10 was shown to harbour genes encoding salivaricins A3, G32, streptin and slnA1 lantibiotic-like protein. Strain GT2 was shown to harbour genes encoding a large non-lantibiotic bacteriocin (salivaricin-MPS). A new medium for maximum biomass production buffered with 2-(N-morpholino)ethanesulfonic acid (MES) was developed and showed better biomass accumulation compared with other commercial media. Furthermore, we extracted and purified salivaricin 9 (by strain NU10) and salivaricin G32 (by strain YU10) from S. salivarius cells grown aerobically in this medium. In addition to bacteriocin production, S. salivarius strains produced levan-sucrase which was detected by a specific ESI-LC-MS/MS method which indicates additional health benefits from the developed strains.

Conclusion: The current study established the bacteriocin, levan-sucrase production and basic safety features of S. salivarius strains isolated from healthy Malaysian subjects demonstrating their potential for use as probiotics. A new bacteriocin-production medium was developed with potential scale up application for pharmaceuticals and probiotics from S. salivarius generating different lantibiotics. This is relevant for the clinical management of oral cavity and upper respiratory tract in the human population.

Citing Articles

Whole genome sequence analysis of C7 isolated from pig feces revealed three bacteriocin gene clusters.

Yoo J, Mendoza R, Hwang I, Kang D J Anim Sci Technol. 2022; 64(5):1008-1011.

PMID: 36287741 PMC: 9574610. DOI: 10.5187/jast.2022.e55.

Effect of a bacteriocin-producing on the pathogen in a model of the human distal colon.

Lawrence G, McCarthy N, Walsh C, Kunyoshi T, Lawton E, OConnor P Gut Microbes. 2022; 14(1):2100203.

PMID: 35877697 PMC: 9318236. DOI: 10.1080/19490976.2022.2100203.

Dysbiosis of the Salivary Microbiome is Associated with Hypertension and Correlated with Metabolic Syndrome Biomarkers.

Sohail M, Hedin L, Al-Asmakh M Diabetes Metab Syndr Obes. 2021; 14:4641-4653.

PMID: 34858042 PMC: 8630402. DOI: 10.2147/DMSO.S325073.

Listeriolysin S: A bacteriocin from that induces membrane permeabilization in a contact-dependent manner.

Meza-Torres J, Lelek M, Quereda J, Sachse M, Manina G, Ershov D Proc Natl Acad Sci U S A. 2021; 118(40).

PMID: 34599102 PMC: 8501752. DOI: 10.1073/pnas.2108155118.

A New Approach to Harness Probiotics Against Common Bacterial Skin Pathogens: Towards Living Antimicrobials.

Khalfallah G, Gartzen R, Moller M, Heine E, Lutticken R Probiotics Antimicrob Proteins. 2021; 13(6):1557-1571.

PMID: 33855669 PMC: 8578138. DOI: 10.1007/s12602-021-09783-7.

References

Cotter P, Hill C, Ross R . Bacteriocins: developing innate immunity for food. Nat Rev Microbiol. 2005; 3(10):777-88. DOI: 10.1038/nrmicro1273. View

Wescombe P, Dyet K, Dierksen K, Power D, Jack R, Burton J . Salivaricin G32, a Homolog of the Prototype Streptococcus pyogenes Nisin-Like Lantibiotic SA-FF22, Produced by the Commensal Species Streptococcus salivarius. Int J Microbiol. 2012; 2012:738503. PMC: 3332205. DOI: 10.1155/2012/738503. View

de Paula V, Pinheiro I, Lopes C, Calazans G . Microwave-assisted hydrolysis of Zymomonas mobilis levan envisaging oligofructan production. Bioresour Technol. 2007; 99(7):2466-70. DOI: 10.1016/j.biortech.2007.04.062. View

Mantovani H, Hu H, Worobo R, Russell J . Bovicin HC5, a bacteriocin from Streptococcus bovis HC5. Microbiology (Reading). 2002; 148(Pt 11):3347-3352. DOI: 10.1099/00221287-148-11-3347. View

Ross K, Ronson C, Tagg J . Isolation and characterization of the lantibiotic salivaricin A and its structural gene salA from Streptococcus salivarius 20P3. Appl Environ Microbiol. 1993; 59(7):2014-21. PMC: 182229. DOI: 10.1128/aem.59.7.2014-2021.1993. View

Chen S, Wilson-Stanford S, Cromwell W, Hillman J, Guerrero A, Allen C . Site-directed mutations in the lanthipeptide mutacin 1140. Appl Environ Microbiol. 2013; 79(13):4015-23. PMC: 3697549. DOI: 10.1128/AEM.00704-13. View

Joo N, Ritchie K, Kamarajan P, Miao D, Kapila Y . Nisin, an apoptogenic bacteriocin and food preservative, attenuates HNSCC tumorigenesis via CHAC1. Cancer Med. 2013; 1(3):295-305. PMC: 3544465. DOI: 10.1002/cam4.35. View

Lv W, Cong W, Cai Z . Nisin production by Lactococcus lactis subsp. lactis under nutritional limitation in fed-batch culture. Biotechnol Lett. 2004; 26(3):235-8. DOI: 10.1023/b:bile.0000013721.78288.1d. View

Kleerebezem M . Quorum sensing control of lantibiotic production; nisin and subtilin autoregulate their own biosynthesis. Peptides. 2004; 25(9):1405-14. DOI: 10.1016/j.peptides.2003.10.021. View

10.

Wescombe P, Burton J, Cadieux P, Klesse N, Hyink O, Heng N . Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius. Antonie Van Leeuwenhoek. 2006; 90(3):269-80. DOI: 10.1007/s10482-006-9081-y. View

11.

van de Ven F, Jung G . Structures of lantibiotics studied by NMR. Antonie Van Leeuwenhoek. 1996; 69(2):99-107. DOI: 10.1007/BF00399415. View

12.

JACK R, Tagg J, Ray B . Bacteriocins of gram-positive bacteria. Microbiol Rev. 1995; 59(2):171-200. PMC: 239359. DOI: 10.1128/mr.59.2.171-200.1995. View

13.

Nguyen T, Zhang Z, Huang I, Wu C, Merritt J, Shi W . Genes involved in the repression of mutacin I production in Streptococcus mutans. Microbiology (Reading). 2009; 155(Pt 2):551-556. PMC: 2946218. DOI: 10.1099/mic.0.021303-0. View

14.

Tahara T, Yoshioka S, Utsumi R, Kanatani K . Isolation and partial characterization of bacteriocins produced by Lactobacillus gasseri JCM 2124. FEMS Microbiol Lett. 1997; 148(1):97-100. DOI: 10.1111/j.1574-6968.1997.tb10273.x. View

15.

Burton J, Wescombe P, Moore C, Chilcott C, Tagg J . Safety assessment of the oral cavity probiotic Streptococcus salivarius K12. Appl Environ Microbiol. 2006; 72(4):3050-3. PMC: 1449041. DOI: 10.1128/AEM.72.4.3050-3053.2006. View

16.

Heng N, Haji-Ishak N, Kalyan A, Wong A, Lovric M, Bridson J . Genome sequence of the bacteriocin-producing oral probiotic Streptococcus salivarius strain M18. J Bacteriol. 2011; 193(22):6402-3. PMC: 3209194. DOI: 10.1128/JB.06001-11. View

17.

Dahech I, Belghith K, Hamden K, Feki A, Belghith H, Mejdoub H . Antidiabetic activity of levan polysaccharide in alloxan-induced diabetic rats. Int J Biol Macromol. 2011; 49(4):742-6. DOI: 10.1016/j.ijbiomac.2011.07.007. View

18.

Barbour A, Philip K, Muniandy S . Enhanced production, purification, characterization and mechanism of action of salivaricin 9 lantibiotic produced by Streptococcus salivarius NU10. PLoS One. 2013; 8(10):e77751. PMC: 3797685. DOI: 10.1371/journal.pone.0077751. View

19.

Al-Mahrous M, Upton M . Discovery and development of lantibiotics; antimicrobial agents that have significant potential for medical application. Expert Opin Drug Discov. 2012; 6(2):155-70. DOI: 10.1517/17460441.2011.545387. View

20.

Birri D, Brede D, Nes I . Salivaricin D, a novel intrinsically trypsin-resistant lantibiotic from Streptococcus salivarius 5M6c isolated from a healthy infant. Appl Environ Microbiol. 2011; 78(2):402-10. PMC: 3255740. DOI: 10.1128/AEM.06588-11. View